content

FDA approves new indication for Novartis drug Afinitorยฎ for progressive, nonfunctional GI and lung neuroendocrine tumors

Novartis announced that the United States FDA approved Afinitorยฎ tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors of gastrointestinal...

Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer Antibody-Drug

Mersana Therapeutics and Takeda Pharmaceutical Company Limited announced that they have entered a new strategic partnership granting Takeda rights to Mersanaโ€™s lead product candidate,...

U.S. FDA Accepts Filing Of Cardiovascular Outcomes Data For Jardianceยฎ (Empagliflozin)

The U.S. FDA accepted a supplemental New Drug Application for Jardiance based on cardiovascular risk reduction data from the landmark EMPA-REG OUTCOMEยฎ trial.ย  ...

FDA Approves Basaglarยฎ (insulin glargine injection), a Long-Acting Insulin Treatment

Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc announced that the U.S. FDA granted approval for Basaglar 100 units/mL. BASAGLAR is a long-acting...

Beximco Pharma forms JV with Malaysia-based BioCare Manufacturing

Beximco Pharmaceuticals Limited the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing...

Alcon spotlights DAILIES TOTAL1ยฎ contact lenses in national television campaign

TV spot showcases the science behind the ultimate breathability and comfort of DAILIES TOTAL1ยฎ contact lenses Fort Worth, Texas- Alcon, the...

Lilly to Present New Clinical Data at 75th American Diabetes Associationยฎ Scientific Sessions

New clinical data demonstrating the range of treatment options represented in Lilly's diabetes portfolio will be presented in 79 abstracts on June 5-9, at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read